http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.
변환된 중국어를 복사하여 사용하시면 됩니다.
High-Dose Chemotherapy with Autologous Stem Cell Supportin Patients with Ovarian Cancer
Takao Shinozuka 가톨릭중앙의료원 가톨릭암센터 1994 암심포지움 Vol.- No.1
About 60~70% of patients with ovarian cancer at-e diagnosed as stage Ⅲ or Ⅳ at presentation. The standard therapeutic approach of cytoreductive surgery and cisplatin-based combination-chemotherapy for such cases confers temporary remission in over 60% of the patients. However, relapses are seen in over half such patients within a few years, decreasing their S-year survival rate to between 20 and 30%. Therefore, the development of a more effective therapeutic approach has been awaited for improvement of long term prognosis,